ES2087056T3 - 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. - Google Patents
2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6.Info
- Publication number
- ES2087056T3 ES2087056T3 ES87100277T ES87100277T ES2087056T3 ES 2087056 T3 ES2087056 T3 ES 2087056T3 ES 87100277 T ES87100277 T ES 87100277T ES 87100277 T ES87100277 T ES 87100277T ES 2087056 T3 ES2087056 T3 ES 2087056T3
- Authority
- ES
- Spain
- Prior art keywords
- substituted
- pirimidinamines
- positions
- pyrimidinamines
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
ESTA PREPARACION DESCRIBE NUEVAS 2-PIRIMIDINAMINAS 4,5,6 SUSTITUIDAS-N-(FENILSUSTITUIDAS) QUE TIENEN ACTIVIDAD ANTIASMATICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81795186A | 1986-01-13 | 1986-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2087056T3 true ES2087056T3 (es) | 1996-07-16 |
Family
ID=25224278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87100277T Expired - Lifetime ES2087056T3 (es) | 1986-01-13 | 1987-01-12 | 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0233461B2 (es) |
JP (1) | JPH0780857B2 (es) |
KR (1) | KR900004693B1 (es) |
AT (1) | ATE135699T1 (es) |
AU (2) | AU591223B2 (es) |
BR (1) | BR1100989A (es) |
CA (1) | CA1320201C (es) |
DE (1) | DE3751742T3 (es) |
DK (1) | DK171251B1 (es) |
ES (1) | ES2087056T3 (es) |
FI (1) | FI91150C (es) |
GR (1) | GR3019455T3 (es) |
HU (1) | HU198708B (es) |
IE (1) | IE74202B1 (es) |
NZ (1) | NZ218924A (es) |
PH (1) | PH25056A (es) |
SG (1) | SG47583A1 (es) |
ZA (1) | ZA87219B (es) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966622A (en) * | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
FR2632521B1 (fr) * | 1988-06-10 | 1990-09-14 | Rhone Poulenc Sante | Nouveaux derives de la phenothiazine, leur preparation et les compositions pharmaceutiques qui les contiennent |
GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
IE62023B1 (en) * | 1989-01-02 | 1994-12-14 | Boots Co Plc | Therapeutic agents |
IN172842B (es) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
CN1037346C (zh) * | 1990-06-29 | 1998-02-11 | 布茨公司 | 降血糖的脒类和胍类的制备方法 |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5162328A (en) * | 1991-12-31 | 1992-11-10 | American Cyanamid Company | N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
TW225528B (es) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
AU693475B2 (en) * | 1993-10-01 | 1998-07-02 | Novartis Ag | Pyrimidineamine derivatives and processes for the preparation thereof |
EP0672042B1 (en) * | 1993-10-01 | 2006-05-03 | Novartis AG | Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
JP2983636B2 (ja) * | 1993-10-01 | 1999-11-29 | ノバルティス アクチェンゲゼルシャフト | 薬理学的に活性なピリジン誘導体及びその製造方法 |
GB9326600D0 (en) * | 1993-12-22 | 1994-03-02 | Celltech Ltd | Chemical compounds |
EP0738268B1 (en) * | 1993-12-22 | 2004-03-03 | Celltech R&D Limited | Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412573D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526243D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
ZA9610687B (en) | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
EP0888335A4 (en) * | 1996-03-13 | 2002-01-02 | Smithkline Beecham Corp | NEW PYRIMIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CYTOKININ MEDIATOR DISEASES |
GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9622363D0 (en) | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
WO1998028281A1 (en) * | 1996-12-23 | 1998-07-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
CA2348234A1 (en) * | 1998-10-29 | 2000-05-11 | Chunjian Liu | Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
ATE253915T1 (de) | 1999-06-30 | 2003-11-15 | Merck & Co Inc | Src-kinase hemmende verbindungen |
US6316444B1 (en) | 1999-06-30 | 2001-11-13 | Merck & Co., Inc. | SRC kinase inhibitor compounds |
US6329380B1 (en) | 1999-06-30 | 2001-12-11 | Merck & Co., Inc. | SRC kinase inhibitor compounds |
GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
CA2400447C (en) * | 2000-02-17 | 2008-04-22 | Amgen Inc. | Kinase inhibitors |
CN100355751C (zh) * | 2000-03-29 | 2007-12-19 | 西克拉塞尔有限公司 | 2-取代的4-杂芳基-嘧啶、其组合物及其用途 |
US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
US7122544B2 (en) * | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
EP1423388B1 (en) | 2001-02-20 | 2008-12-03 | AstraZeneca AB | 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
EP1430051B1 (en) | 2001-09-28 | 2006-12-27 | Cyclacel Limited | N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds |
NZ531853A (en) | 2001-11-01 | 2006-02-24 | Janssen Pharmaceutica Nv | Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
BR0213790A (pt) * | 2001-11-01 | 2004-12-07 | Janssen Pharmaceutica Nv | Derivados de aminobenzamida como inibidores de glicogênio sintase cinase 3beta |
AR038368A1 (es) | 2002-02-01 | 2005-01-12 | Novartis Ag | Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento |
GB0222514D0 (en) | 2002-09-27 | 2002-11-06 | Novartis Ag | Organic compounds |
GB0229581D0 (en) * | 2002-12-19 | 2003-01-22 | Cyclacel Ltd | Use |
MX2007002169A (es) | 2004-08-27 | 2007-08-14 | Cyclacel Ltd | Inhibidores de cdk de purina y pirimidina y su uso para el tratamiento de enfermedades inmunes. |
EP1831207B1 (en) | 2004-12-17 | 2012-11-14 | Amgen Inc. | Aminopyrimidine compounds as plk inhibitors |
GB0500492D0 (en) * | 2005-01-11 | 2005-02-16 | Cyclacel Ltd | Compound |
GB0520958D0 (en) | 2005-10-14 | 2005-11-23 | Cyclacel Ltd | Compound |
US7803806B2 (en) | 2005-11-03 | 2010-09-28 | Sgx Pharmaceuticals, Inc. | Pyrimidinyl-thiophene kinase modulators |
CA2672518A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Organic compounds and their uses |
ES2535166T3 (es) * | 2007-09-04 | 2015-05-06 | The Scripps Research Institute | Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas |
ATE535515T1 (de) | 2008-01-11 | 2011-12-15 | Hoffmann La Roche | Modulatoren für amyloid beta |
RU2010137300A (ru) * | 2008-02-22 | 2012-03-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Модуляторы бета-амилоида |
CA2736924C (en) | 2008-10-09 | 2016-06-28 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
JP5378532B2 (ja) | 2008-11-10 | 2013-12-25 | エフ.ホフマン−ラ ロシュ アーゲー | 複素環γ−セクレターゼモジュレーター |
US8513242B2 (en) | 2008-12-12 | 2013-08-20 | Cystic Fibrosis Foundation Therapeutics, Inc. | Pyrimidine compounds and methods of making and using same |
US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
US8334292B1 (en) | 2010-06-14 | 2012-12-18 | Cystic Fibrosis Foundation Therapeutics, Inc. | Pyrimidine compounds and methods of making and using same |
WO2013035102A1 (en) | 2011-09-05 | 2013-03-14 | Natco Pharma Limited | Processes for the preparation of imatinib base and intermediates thereof |
RU2486180C1 (ru) * | 2011-11-02 | 2013-06-27 | Общество с ограниченной ответственностью "ТехноХим" (ООО "ТехноХим") | Способ получения 2-ариламино-4-гетарилпиримидинов |
WO2014055972A2 (en) * | 2012-10-05 | 2014-04-10 | The Regents Of The University Of California | A new chemical entity useful for treating various diseases |
CN114181199B (zh) * | 2020-09-15 | 2023-09-26 | 成都赜灵生物医药科技有限公司 | 2,4-二取代嘧啶衍生物及其制备方法和用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB735702A (en) * | 1952-03-18 | 1955-08-24 | Wellcome Found | Improvements in and relating to 2,4-diaminopyrimidines and methods of making the same |
US4512993A (en) * | 1983-07-25 | 1985-04-23 | Sterling Drug Inc. | 4(Or 5)-(pyridinyl)-2-pyrimidinamines and cardiotonic use thereof |
US4504482A (en) * | 1983-07-28 | 1985-03-12 | Sterling Drug Inc. | [5(or 4)-(Pyridinyl)-2-pyrimidinyl]ureas and cardiotonic use thereof |
GB8412184D0 (en) * | 1984-05-12 | 1984-06-20 | Fisons Plc | Biologically active nitrogen heterocycles |
EP0164204A1 (en) † | 1984-05-12 | 1985-12-11 | FISONS plc | Novel pharmaceutically useful pyrimidines |
US4725600A (en) † | 1984-07-13 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent |
WO1986004583A1 (en) * | 1985-02-05 | 1986-08-14 | The Upjohn Company | 4-substituted-6-aryl pyrimidine compounds |
US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
-
1987
- 1987-01-12 SG SG1996002948A patent/SG47583A1/en unknown
- 1987-01-12 DE DE3751742T patent/DE3751742T3/de not_active Expired - Fee Related
- 1987-01-12 EP EP87100277A patent/EP0233461B2/en not_active Expired - Lifetime
- 1987-01-12 ES ES87100277T patent/ES2087056T3/es not_active Expired - Lifetime
- 1987-01-12 AT AT87100277T patent/ATE135699T1/de not_active IP Right Cessation
- 1987-01-13 AU AU67518/87A patent/AU591223B2/en not_active Ceased
- 1987-01-13 NZ NZ218924A patent/NZ218924A/en unknown
- 1987-01-13 FI FI870113A patent/FI91150C/fi not_active IP Right Cessation
- 1987-01-13 DK DK015187A patent/DK171251B1/da not_active IP Right Cessation
- 1987-01-13 JP JP62005867A patent/JPH0780857B2/ja not_active Expired - Lifetime
- 1987-01-13 PH PH34715A patent/PH25056A/en unknown
- 1987-01-13 HU HU87100A patent/HU198708B/hu not_active IP Right Cessation
- 1987-01-13 CA CA000527173A patent/CA1320201C/en not_active Expired - Fee Related
- 1987-01-13 IE IE7487A patent/IE74202B1/en not_active IP Right Cessation
- 1987-01-13 ZA ZA87219A patent/ZA87219B/xx unknown
- 1987-01-15 KR KR1019870000280A patent/KR900004693B1/ko not_active IP Right Cessation
-
1990
- 1990-02-28 AU AU50578/90A patent/AU621461B2/en not_active Ceased
-
1996
- 1996-03-29 GR GR950402384T patent/GR3019455T3/el unknown
-
1997
- 1997-05-14 BR BR1100989-6A patent/BR1100989A/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE3751742T3 (de) | 2002-11-21 |
DE3751742D1 (de) | 1996-04-25 |
AU621461B2 (en) | 1992-03-12 |
DK15187A (da) | 1987-07-14 |
KR870007154A (ko) | 1987-08-17 |
JPS62223177A (ja) | 1987-10-01 |
DE3751742T2 (de) | 1996-11-21 |
AU6751887A (en) | 1987-07-16 |
IE870074L (en) | 1987-07-13 |
GR3019455T3 (en) | 1996-06-30 |
EP0233461A2 (en) | 1987-08-26 |
FI870113A0 (fi) | 1987-01-13 |
KR900004693B1 (ko) | 1990-07-02 |
HUT43582A (en) | 1987-11-30 |
NZ218924A (en) | 1990-04-26 |
FI91150C (fi) | 1994-05-25 |
EP0233461B1 (en) | 1996-03-20 |
IE74202B1 (en) | 1997-07-16 |
AU5057890A (en) | 1990-07-26 |
ATE135699T1 (de) | 1996-04-15 |
EP0233461A3 (en) | 1988-05-25 |
SG47583A1 (en) | 1998-04-17 |
BR1100989A (pt) | 1999-11-09 |
CA1320201C (en) | 1993-07-13 |
EP0233461B2 (en) | 2002-05-29 |
FI870113A (fi) | 1987-07-14 |
JPH0780857B2 (ja) | 1995-08-30 |
DK171251B1 (da) | 1996-08-12 |
DK15187D0 (da) | 1987-01-13 |
FI91150B (fi) | 1994-02-15 |
ZA87219B (en) | 1987-08-26 |
PH25056A (en) | 1991-01-28 |
AU591223B2 (en) | 1989-11-30 |
HU198708B (en) | 1989-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2087056T3 (es) | 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. | |
DK172089D0 (da) | 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf | |
DE3764686D1 (de) | N,n'-dihalo-2-imidazolidinone. | |
DK336587D0 (da) | Alfa-aryl-alfa-phenylethyl-1h-1,2,4-triazol-1-propannitriler | |
FI850275A0 (fi) | Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat. | |
FI875619A0 (fi) | 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner. | |
DE3788494D1 (de) | Harnstoffe. | |
DE3783176T2 (de) | Bis-dioxopiperazin-abkoemmlinge. | |
IT1212143B (it) | Composizione ad attivita'tricogena. | |
ATE93540T1 (de) | Menschliche pankreaselastase i. | |
DE3862709D1 (de) | Querstromventilator. | |
FI875397A0 (fi) | Substituerade aminometyl-5,6,7,8 -tetrahydronaftyl-oxiaettikasyror, nya mellanprodukter, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel. | |
ATE69235T1 (de) | Erythromycin-a-derivate, modifiziert in position- c-12. | |
FR2593066B1 (fr) | Compositions therapeutiques a base de derives de 3-alkoxyflavones et nouveaux derives de 3-alkoxyflavones. | |
ES2073495T3 (es) | Benzotiazepinas. | |
FI891353A (fi) | Bytesmekanism foer radioaktiva prov i en foer massaundersoekningar avsedd gammaraeknare. | |
DE3784424T2 (de) | Seitenaustauschsupervisor. | |
DK291687A (da) | 2-phenylacetyl-1,3,5-cyklohexantrioner | |
IT8618806V0 (it) | Lava - pentole n.2 | |
IT8917966A0 (it) | Cuoio fantasioso. | |
BR8707603A (pt) | Copolimeros de etileno e 1,3-butadieno | |
IT8659815V0 (it) | Giocattolo aerostatico. | |
ATE70312T1 (de) | Gerbstoff. | |
FI914395A0 (fi) | Nya 5,6-substituerade 2,4-kinazo- lindiaminer. | |
DE3760738D1 (de) | 1,1-dialkoxy-2-methyl-4,4-diacyloxybutenes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 0233461 Country of ref document: ES |